Can SLC19A1 80G>A polymorphisms predict risk of extremely delayed MTX excretion after high dose of methotrexate?

Maria Moeller Rasmussen; Regitse Hoejgaard Christensen; Jannie Gregers; Jesper Heldrup; Jacob Nersting; Kjeld Schmiegelow

doi:10.1097/MPH.0b013e318290c11c

Can SLC19A1 80G>A polymorphisms predict risk of extremely delayed MTX excretion after high dose of methotrexate?

Maria Moeller Rasmussen, Regitse Hoejgaard Christensen, Jannie Gregers, Jesper Heldrup, Jacob Nersting, Kjeld Schmiegelow

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of Pediatric Hematology/Oncology
Vol/bind	35
Udgave nummer	5
Sider (fra-til)	417-8
Antal sider	2
ISSN	1077-4114
DOI	https://doi.org/10.1097/MPH.0b013e318290c11c
Status	Udgivet - jul. 2013

Adgang til dokumentet

10.1097/MPH.0b013e318290c11c

Citationsformater

@article{fe10218f8c654b9483d259b30da0b8c3,

title = "Can SLC19A1 80G>A polymorphisms predict risk of extremely delayed MTX excretion after high dose of methotrexate?",

keywords = "Child, Genotype, Humans, Methotrexate, Polymorphism, Single Nucleotide, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Reduced Folate Carrier Protein",

author = "Rasmussen, {Maria Moeller} and Christensen, {Regitse Hoejgaard} and Jannie Gregers and Jesper Heldrup and Jacob Nersting and Kjeld Schmiegelow",

year = "2013",

month = jul,

doi = "10.1097/MPH.0b013e318290c11c",

language = "English",

volume = "35",

pages = "417--8",

journal = "Journal of Pediatric Hematology/Oncology",

issn = "1077-4114",